S-1 · primary offering
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 21 of INTENSITY THERAPEUTICS, INC.'s SEC filings and found 7 warrant series, 1 ATM program, 2 shelf registrations, 2 S-1 registrations and 1 completed offering on file for INTS. The latest dilution event on file is ATM sales on Aug 11, 2026. Analysis updated Oct 6, 2026.
Raise routes on file: active ATM + effective shelf + effective S-1 · latest dilution event 84 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 11, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2025
Proposed maximum
Shares registered
Issued 2024
Proposed maximum
Shares registered
Issued 2025
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z